To better comprehend the connection between the risk score and immune response, we calculated the association between the risk score and the expression levels of core immune checkpoints in GBM, such as CD28, TIM-3, B7-H3, PD-1, B7-H4, CD40, LAG3, and PD-L1. The gene discussed is CD276; the disease is glioblastoma.